N

Neurocrine Biosciences

Develops and markets neurology-focused therapies

Senior Director - Global Drug Safety MD

Biology & BiotechPosted on Nov 10
Full-timeSan Diego, CA, USA

About the Job

Requirements

  • An M.D. degree and accredited residency in a relevant clinical specialty, such as Internal Medicine, Family Practice, or Neurology.
  • Board certification and clinical or industry experience are required.
  • At least 4 years of relevant experience.
  • Pharmacovigilance experience in a pharmaceutical or biotechnology company, preferably pharmaceutical, including experience in signal management such as signal detection, evaluation, and assessment.
  • Comprehensive knowledge of pharmacovigilance, safety surveillance, and risk management, with recognized medical and scientific expertise.
  • Ability to evaluate complex safety data, apply sound medical judgment, and develop practical strategies to address emerging safety concerns.
  • Strategic thinking and problem-solving skills, including translating scientific insights into actionable recommendations and business decisions.
  • Ability to influence senior leaders and cross-functional stakeholders.

Responsibilities

  • Serve as the medical safety expert for assigned marketed and/or investigational therapies, with accountability for ongoing evaluation and management of their safety profiles.
  • Lead development and execution of global safety surveillance and risk management strategies, proactively identifying, assessing, and mitigating emerging safety concerns.
  • Provide strategic medical guidance to senior leadership and cross-functional governance teams on safety-related decisions, evolving benefit-risk considerations, and product lifecycle management.
  • Drive safety strategy and decision-making by interpreting complex clinical and post-marketing safety data.
  • Provide medical guidance for signal detection, evaluation, assessment, and management, including investigation of emerging safety trends and potential risks.
  • Lead aggregate safety data reviews and provide medical interpretation for ongoing safety surveillance and benefit-risk evaluations.
  • Oversee and contribute to medical review of individual case safety reports, including seriousness, expectedness, causality assessments, and clinical interpretation, as needed.
  • Partner with pharmacovigilance and safety operations teams to ensure robust, compliant, and scientifically sound safety surveillance practices.
  • Provide medical oversight and strategic input into safety-related regulatory submissions and periodic safety reports, including DSURs, PBRERs, PSURs, PADERs, and IND Annual Reports, as applicable.
  • Contribute to safety-related regulatory documentation, including product labeling, Company Core Data Sheets, Investigator Brochures, Integrated Summaries of Safety, clinical protocols, and informed consent documents.
  • Support responses to regulatory authority inquiries and participate in safety governance discussions to inform product-level decisions.
  • Develop and refine risk management strategies across development and post-approval settings, aligned with evolving regulatory expectations.
  • Act as a trusted medical safety partner to Clinical Development, Regulatory Affairs, Medical Affairs, and other key stakeholders, influencing decisions that affect product safety and patient care.
  • Represent Drug Safety on multidisciplinary teams, contributing to clinical research strategies, development plans, and ongoing product lifecycle activities.
  • Provide leadership in strengthening safety surveillance processes, operational practices, and organizational capabilities.
  • Mentor and guide safety professionals and cross-functional colleagues, with potential responsibility for direct reports and resource management.

About the Company

Neurocrine Biosciences

Develops and markets neurology-focused therapies

Neurocrine Biosciences develops and commercializes medicines for neurological and endocrine diseases. Its work centers on discovering and developing treatments, with INGREZZA (valbenazine) approved to treat adults with tardive dyskinesia and a pipeline of other drug candidates in various clinical stages. The company earns revenue from sales of approved medicines and from milestones and royalties from collaborations with partners. By focusing on both neurological and endocrine conditions, Neurocrine targets patients and healthcare professionals seeking therapies for conditions such as tardive dyskinesia, Parkinson's disease, and endometriosis. Its main goal is to bring therapies to market through development and commercialization, supported by ongoing research across its clinical programs to address unmet medical needs in these areas.

Company size
1,001-5,000
Company stage
IPO
Headquarters
San Diego, CA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Neurocrine Biosciences

See more jobs